Advancements in Forecasting Liver Cytosol Metabolic Stability: A Comprehensive Update on Machine Learning Predictive Models

Clicks: 29
ID: 330818
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #28 of 173 articles by views in Bioinformatics advances

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 173 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Motivation Drug metabolism plays a key role in determining a compound’s pharmacokinetics and overall success in development. While cytochrome P450 enzymes have been widely studied, non-cytochrome P450 enzymes, such as aldehyde oxidase, xanthine oxidase, and carboxylesterases, are increasingly recognized as important contributors to drug clearance. Since standard liver microsomal screening fails to include these enzymes, stability assessment using liver cytosols is essential to prevent late-stage development failures. Results We expanded our dataset to over 7000 cytosol metabolic stability measurements for human, mouse, and rat. We developed and evaluated machine learning models using molecular fingerprints and descriptors, with performance assessed on scaffold-based external test sets. To address class imbalance, stratified bagging improved identification of unstable compounds. The final models achieved an external balanced accuracy of 0.812 for human and 0.658 for mouse. The rat model, built from a dataset with severe minority class scarcity, reached a balanced accuracy of 0.724 and the highest area under the curve (0.886). This work improves the balanced accuracy of our previous human model by 29.7% and introduces the first publicly available models for mouse and rat. Availability and implementation These in silico models are freely accessible through the ADME@NCATS platform for early-stage assessment of species-specific cytosol metabolic stability.
Reference Key
openalex_W7215120052 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal Bioinformatics advances
Year 2026
DOI
10.1093/bioadv/vbag291
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.